• Martin Hauer-Jensen, Junru Wang, Marjan Boerma, Qiang Fu, and James W Denham.
• Department of Surgery and Pathology, University of Arkansas for Medical Sciences and Surgery Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA. mhjensen@life.uams.edu
• Curr Opin Support Palliat Care. 2007 Apr 1; 1 (1): 23-9.

Purpose Of ReviewTo summarize current knowledge about gastrointestinal radiation toxicity, with emphasis on mechanisms and clinical diagnosis and management.Recent FindingsWhile there has been only modest change in cancer incidence and cancer mortality rates during the past 30 years, the number of cancer survivors has more than doubled. Moreover, the recognition of uncomplicated cancer cure as the ultimate goal in oncology has intensified efforts to prevent, diagnose, and manage side effects of radiation therapy. These efforts have been facilitated by recent insight into the underlying pathophysiology.SummaryThe risk of injury to the intestine is dose limiting during abdominal and pelvic radiation therapy. Delayed bowel toxicity is difficult to manage and adversely impacts the quality of life of cancer survivors. More than 200,000 patients per year receive abdominal or pelvic radiation therapy, and the estimated number of cancer survivors with postradiation intestinal dysfunction is 1.5-2 million. Worthwhile progress towards reducing toxicity of radiation therapy has been made by dose-sculpting treatment techniques. Approaches derived from an improved understanding of the pathophysiology of bowel injury, however, will result in further advances. This article discusses the mechanisms of radiation-induced bowel toxicity and reviews current principles in diagnosis and management.

17 keywords...

hide…